NAICS Code 541715-20 - Pharmaceutical Information

Marketing Level - NAICS 8-Digit

Business Lists and Databases Available for Marketing and Research

Total Verified Companies: 25
Contact Emails: 333
Company Websites: 21
Phone Numbers: 19
Business Addresses: 25
Companies with Email: 15
Reach new customers, connect with decision makers, and grow your business.
Pricing from $0.05 to $0.25 per lead

Business List Pricing Tiers

Quantity of Records Price Per Record Estimated Total (Max in Tier)
0 - 1,000 $0.25 Up to $250
1,001 - 2,500 $0.20 Up to $500
2,501 - 10,000 $0.15 Up to $1,500
10,001 - 25,000 $0.12 Up to $3,000
25,001 - 50,000 $0.09 Up to $4,500
50,000+ Contact Us for a Custom Quote

What's Included in Every Standard Data Package

  • Company Name
  • Contact Name (where available)
  • Job Title (where available)
  • Full Business & Mailing Address
  • Business Phone Number
  • Industry Codes (Primary and Secondary SIC & NAICS Codes)
  • Sales Volume
  • Employee Count
  • Website (where available)
  • Years in Business
  • Location Type (HQ, Branch, Subsidiary)
  • Modeled Credit Rating
  • Public / Private Status
  • Latitude / Longitude
  • ...and more (Inquire)

Boost Your Data with Verified Email Leads

Enhance your list or opt for a complete 100% verified email list – all for just $0.10 per email!

Ideal for: Direct Mailing Email Campaigns Calling Market ResearchFree Sample & Report, Custom Lists, and Expert Support — All Included

NAICS Code 541715-20 Description (8-Digit)

Pharmaceutical Information is a subdivision of the NAICS Code 541715 that involves the collection, analysis, and dissemination of information related to pharmaceuticals. This industry is responsible for providing accurate and up-to-date information on drugs, including their uses, side effects, interactions, and dosages. Pharmaceutical Information is essential for healthcare professionals, patients, and regulatory agencies to make informed decisions about the use of drugs.

Parent Code - Official US Census

Official 6‑digit NAICS codes serve as the parent classification used for government registrations and documentation. The marketing-level 8‑digit codes act as child extensions of these official classifications, providing refined segmentation for more precise targeting and detailed niche insights. Related industries are listed under the parent code, offering a broader context of the industry environment. For further details on the official classification for this industry, please visit the U.S. Census Bureau NAICS Code 541715 page

Tools

Tools commonly used in the Pharmaceutical Information industry for day-to-day tasks and operations.

  • Drug databases
  • Clinical trial databases
  • Medical literature databases
  • Pharmacovigilance software
  • Drug safety databases
  • Electronic health records
  • Data mining software
  • Statistical analysis software
  • Medical coding systems
  • Regulatory compliance software

Industry Examples of Pharmaceutical Information

Common products and services typical of NAICS Code 541715-20, illustrating the main business activities and contributions to the market.

  • Drug interactions
  • Drug dosages
  • Drug side effects
  • Drug contraindications
  • Drug efficacy
  • Drug safety
  • Drug approvals
  • Drug labeling
  • Drug recalls
  • Drug pricing

History

A concise historical narrative of NAICS Code 541715-20 covering global milestones and recent developments within the United States.

  • The "Pharmaceutical Information" industry has a long history of providing valuable information to the pharmaceutical industry. In the early days, this industry was focused on providing information on drugs and their effects. In the 1960s, the industry began to focus on clinical trials and the development of new drugs. The 1980s saw the introduction of computer technology, which revolutionized the industry by allowing for the storage and analysis of large amounts of data. In recent years, the industry has continued to evolve with the introduction of artificial intelligence and machine learning, which have the potential to greatly improve drug development and patient outcomes. In the United States, the "Pharmaceutical Information" industry has seen significant growth in recent years. This growth can be attributed to several factors, including the increasing demand for personalized medicine, the rise of big data, and the growing importance of real-world evidence. The industry has also benefited from advances in technology, such as the increasing use of electronic health records and the development of new data analytics tools. Overall, the "Pharmaceutical Information" industry is poised for continued growth and innovation in the years to come.